Discovery of DS-9300: A Highly Potent, Selective, and Once-Daily Oral EP300/CBP Histone Acetyltransferase Inhibitor
Journal of Medicinal Chemistry · 12.01.2023 · 66 (1) · 695-715
DOI: 10.1021/acs.jmedchem.2c01641 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 26.12.2022. Verfasst von Ryutaro Kanada und 22 weiteren Autor:innen. Beteiligte Einrichtung: Daiichi Sankyo Co., Ltd., 1-2-58 Hiromachi, Shinagawa-ku, Tokyo140-8710, Japan. Hauptthemen laut MEDLINE: Histones, Histone Acetyltransferases. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Daiichi Sankyo Co., Ltd., 1-2-58 Hiromachi, Shinagawa-ku, Tokyo140-8710, Japan.
- Daiichi Sankyo RD Novare Co., Ltd., 1-16-13 Kitakasai, Edogawa-ku, Tokyo134-8630, Japan.
- Division of Genome Biology, National Cancer Center Research Institute, 1-1 Tsukiji 5-chome, Chuo-ku, Tokyo104-0045, Japan.
- Division of Cancer Therapeutics, National Cancer Center Research Institute, 1-1 Tsukiji 5-chome, Chuo-ku, Tokyo104-0045, Japan.
ORCID-Profile: Ryutaro Kanada, Mizuki Takahashi
Zitieren
APA
Kanada, R., Kagoshima, Y., Suzuki, T., Nakamura, A., Funami, H., Watanabe, J., Asano, M., Takahashi, M., Ubukata, O., Suzuki, K., Aikawa, T., Sato, K., Goto, M., Setsu, G., Ito, K., Kihara, K., Kuroha, M., Kohno, T., Ogiwara, H., …, & Naito, H. (2023). Discovery of DS-9300: A Highly Potent, Selective, and Once-Daily Oral EP300/CBP Histone Acetyltransferase Inhibitor. Journal of Medicinal Chemistry, 66(1), 695-715. https://doi.org/10.1021/acs.jmedchem.2c01641
Vancouver
Kanada R, Kagoshima Y, Suzuki T, Nakamura A, Funami H, Watanabe J, et al. Discovery of DS-9300: A Highly Potent, Selective, and Once-Daily Oral EP300/CBP Histone Acetyltransferase Inhibitor. Journal of Medicinal Chemistry. 2023;66(1):695-715. doi:10.1021/acs.jmedchem.2c01641
BibTeX
@article{Kanada2023,
author = {Kanada, Ryutaro and Kagoshima, Yoshiko and Suzuki, Takashi and Nakamura, Akifumi and Funami, Hideaki and Watanabe, Jun and Asano, Masayoshi and Takahashi, Mizuki and Ubukata, Osamu and Suzuki, Kanae and Aikawa, Tomoya and Sato, Kazumi and Goto, Megumi and Setsu, Genzui and Ito, Kentaro and Kihara, Kawori and Kuroha, Mutsumi and Kohno, Takashi and Ogiwara, Hideaki and Isoyama, Takeshi and Tominaga, Yuichi and Higuchi, Saito and Naito, Hiroyuki},
title = {Discovery of DS-9300: A Highly Potent, Selective, and Once-Daily Oral EP300/CBP Histone Acetyltransferase Inhibitor},
journal = {Journal of Medicinal Chemistry},
year = {2023},
volume = {66},
number = {1},
pages = {695--715},
doi = {10.1021/acs.jmedchem.2c01641}
}
EUVIMED